Gene | Human | Mouse | ||||||
Map location | Mode of inheritance | Phenotype in mutants | Penetrance of the HSCR trait | Refs | Natural mutant | Knockout | Refs | |
RET | 10q11.2 | AD | HSCR | 70% in males and 50% in females for CDS mutations | 43, 44, 60, 61 | – | LRenal agenesis | 82 |
GDNF | 5p13 | AD | HSCR | 5 cases reportedLow penetrance | 102–104 | – | L | 92–94 |
Renal agenesis | ||||||||
NTN | 19p13 | AD | HSCR | 1 case reported | 105 | – | – | |
SOX10 | 22q13 | AD | WS4 | About 80% | 122–124 | Dom (AD) | LCoat spotting | 125 |
EDNRB | 13q22 | AR/AD | WS4/HSCR | Low | 118, 126–129 | sl (AR) | SCoat spotting | 117 |
EDN3 | 20q13 | AR/AD | WS4/HSCR | 1 case reported | 130 | ls (AR) | SCoat spotting | 119 |
ECE1 | 1p36 | AD | HSCR | 1 case reported | 131 | – | SCoat spottingCraniofacial defects | 132 |
CF and cardiac defect | ||||||||
ZFHX1B (SIP1) | 2q22 | AD | MCA-MR, facial gestal, | 60% | 133–135 | – | Letal at gastrulation | 136 |
PHOX2B | 4p12 | AD | CCHS | 20% | 137, 138 | – | TIANo ANSVentilatory anomalies in Phox2b+/− | 139, 140 |
TCF4 | 18q21 | AD | Epileptic encephalopathy | 1 case | 141–143 | – | Early letalityAbnormal maturation of lymphocytes | 144, 145 |
AD, autosomal dominant; ANS, autonomic nervous system; AR, autosomal recessive; CF, craniofacial; L, long-segment megacolon; MR, mental retardation; S, short-segment megacolon; Spo, sporadic; sl, Piebald lethal; ls, lethal spotting; TIA, total intestinal aganglionosis.